MATURE B-CELL MALIGNANCIES
Clinical trials for MATURE B-CELL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new MATURE B-CELL MALIGNANCIES trials appear
Sign up with your email to follow new studies for MATURE B-CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise in early trial for Hard-to-Treat blood cancers
Disease control OngoingThis early-phase study tests a new drug called BGB-11417 in 64 adults with certain types of blood cancers (B-cell malignancies) that have come back or not responded to prior treatments. The main goals are to find the safest dose and check for side effects. This is not a cure; the…
Matched conditions: MATURE B-CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
New targeted drug shows promise for Hard-to-Treat blood cancers
Disease control OngoingThis early-phase study tests a new drug called sonrotoclax (BGB-11417) in adults with certain blood cancers (B-cell malignancies) that have come back or not responded to prior treatment. The main goals are to find the safest dose and to check for side effects when given alone or …
Matched conditions: MATURE B-CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated May 15, 2026 11:54 UTC